Skip to main content

Advertisement

Table 4 Clinical characteristics of early recurrence

From: Impact of follow-up interval on patients with hepatocellular carcinoma after curative ablation

Characteristics Low risk group High risk group
Short interval Long interval P Short interval Long interval P
Patients 65 25   79 21  
Relapse location (%)    0.868    0.383
 Local 26 (40.6) 11 (44.0)   29 (37.2) 5 (23.8)  
 Intrahepatic distant 37 (57.8) 14 (56.0)   47 (60.3) 15 (71.4)  
 Extrahepatic 1.0 (1.6) 0.0 (0.0)   2 (2.6) 1 (4.8)  
Intrahepatic tumor number 1.0 (1.0) 1.5 (1.0) 0.811 1.0 (1.0) 2.0 (1.0) 0.229
Intrahepatic tumor size (cm) 1.7 (1.5) 1.9 (1.9) 0.718 1.9 (1.5) 1.6 (1.3) 0.797
Curative intent (%) 44.0 (77.2) 18.0 (81.8) 0.886 43 (64.2) 6 (37.5) 0.087
BCLC (%)    0.172    0.028
 0 19 (29.2) 6 (24.0)   15 (19.0) 2 (9.5)  
 A 35 (53.8) 12 (48.0)   46 (58.2) 10 (47.6)  
 B 7 (10.8) 5 (20.0)   8 (10.1) 3 (14.3)  
 C & D 4 (6.2) 2 (8.0)   10 (12.7) 6 (28.6)  
  1. Abbreviations: BCLC Barcelona clinic liver cancer stage
  2. Values are presented as the median (IQR), or n (%)